Transdermal delivery enhanced by magainin pore-forming peptide

J Control Release. 2007 Oct 8;122(3):375-83. doi: 10.1016/j.jconrel.2007.05.031. Epub 2007 Jun 2.

Abstract

In this study we tested the hypothesis that magainin, a peptide known to form pores in bacterial cell membranes, can increase skin permeability by disrupting stratum corneum lipid structure. We further hypothesized that magainin's enhancement requires co-administration with a surfactant chemical enhancer to increase magainin penetration into the skin. In support of these hypotheses, exposure to a known surfactant chemical enhancer, N-lauroyl sarcosine (NLS), in 50% ethanol solution increased in vitro skin permeability to fluorescein 15 fold and the combination of magainin and NLS-ethanol synergistically increased skin permeability 47 fold. In contrast, skin permeability was unaffected by exposure to magainin without co-enhancement by NLS-ethanol. Furthermore, confocal microscopy showed that magainin in the presence of NLS-ethanol penetrated deeply and extensively into stratum corneum, whereas magainin alone penetrated poorly into the skin. Additional analysis by Fourier-transform infrared spectroscopy, X-ray diffraction, and differential scanning calorimetry showed that NLS-ethanol disrupted stratum corneum lipid structure and that the combination of magainin and NLS-ethanol disrupted stratum corneum lipids even further. Altogether, these data suggest that NLS-ethanol increased magainin penetration into stratum corneum, which further increased stratum corneum lipid disruption and skin permeability. We believe this is the first study to demonstrate the use of a pore-forming peptide to increase skin permeability. This study also presents the novel concept of using a first chemical enhancer to increase penetration of a second chemical enhancer into the skin to synergistically increase skin permeability to a model drug.

MeSH terms

  • Administration, Cutaneous
  • Antimicrobial Cationic Peptides / administration & dosage
  • Antimicrobial Cationic Peptides / adverse effects
  • Antimicrobial Cationic Peptides / chemistry
  • Antimicrobial Cationic Peptides / pharmacology*
  • Calorimetry, Differential Scanning
  • Drug Carriers / administration & dosage
  • Drug Carriers / adverse effects
  • Drug Carriers / chemistry
  • Drug Carriers / pharmacology*
  • Epidermis / metabolism*
  • Epidermis / pathology
  • Humans
  • In Vitro Techniques
  • Magainins
  • Microscopy, Fluorescence, Multiphoton
  • Permeability
  • Spectroscopy, Fourier Transform Infrared
  • X-Ray Diffraction
  • Xenopus Proteins / administration & dosage
  • Xenopus Proteins / adverse effects
  • Xenopus Proteins / chemistry
  • Xenopus Proteins / pharmacology*

Substances

  • Antimicrobial Cationic Peptides
  • Drug Carriers
  • Magainins
  • Xenopus Proteins
  • magainin 2 peptide, Xenopus